卡利科辛通过调节巨细胞极化和随后的骨质分化来缓解颗粒诱导的骨解
Hui Jiang1, Yang Wang1, Zhao Tang1
1Department of Orthopedics, The Affiliated Jinling Hospital of Nanjing Medical University, Nanjing, China.
Journal of cellular and molecular medicine
|March 18, 2024
概括
卡利科辛 (CA) 通过重新平衡巨细胞两极分化,减少炎症和促进骨形成,有效治疗周围假肢骨解 (PPO). 这种化合物显示出对抗由磨损颗粒引起的植入物衰竭的前途.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 整形外科 整形外科 整形外科
背景情况:
- 由磨损颗粒驱动的周围假肢骨质溶解 (PPO) 是关节塑性失败的主要原因.
- 不平衡的巨细胞两极分化和骨质生成受损是PPO的关键贡献者.
- 卡利科辛 (CA) 具有已知的抗炎和骨质保护性质.
研究的目的:
- 研究卡利科辛 (CA) 对 (Ti) 颗粒诱导的骨解的治疗作用.
- 为了确定CA对巨细胞两极分化和骨质性缺陷对Ti颗粒的反应的影响.
- 阐明CA对PPO的作用所涉及的信号通路.
主要方法:
- 我们使用了Ti粒子刺激的骨骨解的小鼠模型.
- 在体内和体外实验中使用了微型CT,ELISA,qRT-PCR,免疫光学和西方涂抹.
- 使用MC3T3-E1细胞来评估骨质分化.
主要成果:
- 在小鼠模型中,CA显著缓解了炎症,骨质生成抑制和骨解.
- CA抑制了M1巨细胞的两极分化,并促进了M2两极分化,在体外增强了骨质生成.
- 通过NF-κB信号通路,CA调节了巨细胞的两极分化,减轻了骨质性缺陷.
结论:
- 卡利科辛 (CA) 在治疗磨损颗粒诱导的骨质溶解方面表现出有效性.
- CA重新平衡巨细胞的两极分化,减少炎症,并支持骨质生成.
- CA代表了一种潜在的治疗剂,用于周围假肢骨解.
相关概念视频
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


